{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T07:50:46Z","timestamp":1768290646520,"version":"3.49.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T00:00:00Z","timestamp":1590105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T00:00:00Z","timestamp":1590105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s12028-020-00995-3","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T13:02:40Z","timestamp":1590152560000},"page":"25-34","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Study Design and Rationale"],"prefix":"10.1007","volume":"33","author":[{"name":"the GCS-NeuroCOVID Study","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Frontera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shraddha","family":"Mainali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ericka L.","family":"Fink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney L.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Schober","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Ziai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Menon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick M.","family":"Kochanek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose I.","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raimund","family":"Helbok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Molly","family":"McNett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherry H.-Y.","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,22]]},"reference":[{"key":"995_CR1","doi-asserted-by":"publisher","first-page":"116832","DOI":"10.1016\/j.jns.2020.116832","volume":"413","author":"AA Asadi-Pooya","year":"2020","unstructured":"Asadi-Pooya AA, Simani L. Central nervous system manifestations of COVID-19: a systematic review. J Neurol Sci. 2020;413:116832.","journal-title":"J Neurol Sci"},{"key":"995_CR2","doi-asserted-by":"crossref","unstructured":"Poyiadji N, et al. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology. 2020;1201187.","DOI":"10.1148\/radiol.2020201187"},{"key":"995_CR3","doi-asserted-by":"crossref","unstructured":"Li Y, Wang M, Zhou Y, Jiang C, Xian Y, Mao L, Hong C, Chen S, Wang Y, Wang H, Li M, Jin H, Hu B. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. The Lancet. 2020 (preprint).","DOI":"10.2139\/ssrn.3550025"},{"key":"995_CR4","doi-asserted-by":"crossref","unstructured":"Toscano G, et al. Guillain\u2013Barre syndrome associated with SARS-CoV-2. N Engl J Med. 2020.","DOI":"10.1186\/s42466-020-00066-0"},{"key":"995_CR5","doi-asserted-by":"crossref","unstructured":"Wu Y, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020.","DOI":"10.1016\/j.bbi.2020.03.031"},{"key":"995_CR6","doi-asserted-by":"crossref","unstructured":"Mao L, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020.","DOI":"10.1001\/jamaneurol.2020.1127"},{"key":"995_CR7","doi-asserted-by":"crossref","unstructured":"Klok FA, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res. 2020.","DOI":"10.1016\/j.thromres.2020.04.041"},{"issue":"5","key":"995_CR8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S1474-4422(20)30109-5","volume":"19","author":"H Zhao","year":"2020","unstructured":"Zhao H, et al. Guillain\u2013Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020;19(5):383\u20134.","journal-title":"Lancet Neurol"},{"key":"995_CR9","doi-asserted-by":"crossref","unstructured":"Sedaghat Z, Karimi N. Guillain Barre syndrome associated with COVID-19 infection: a case report. J Clin Neurosci. 2020.","DOI":"10.1016\/j.jocn.2020.06.025"},{"key":"995_CR10","doi-asserted-by":"crossref","unstructured":"Camdessanche JP, et al. COVID-19 may induce Guillain\u2013Barre syndrome. Rev Neurol (Paris). 2020.","DOI":"10.1016\/j.neurol.2020.04.003"},{"key":"995_CR11","doi-asserted-by":"crossref","unstructured":"Virani A, et al. Guillain\u2013Barre syndrome associated with SARS-CoV-2 infection. IDCases. 2020; e00771.","DOI":"10.1016\/j.idcr.2020.e00771"},{"key":"995_CR12","doi-asserted-by":"crossref","unstructured":"Alberti P, et al. Guillain\u2013Barre syndrome related to COVID-19 infection. Neurol Neuroimmunol Neuroinflamm. 2020;7(4).","DOI":"10.1212\/NXI.0000000000000741"},{"key":"995_CR13","doi-asserted-by":"crossref","unstructured":"Padroni M, et al. Guillain\u2013Barre syndrome following COVID-19: new infection, old complication? J Neurol. 2020.","DOI":"10.1007\/s00415-020-09849-6"},{"key":"995_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ijid.2020.03.062","volume":"94","author":"T Moriguchi","year":"2020","unstructured":"Moriguchi T, et al. A first case of meningitis\/encephalitis associated with SARS-coronavirus-2. Int J Infect Dis. 2020;94:55\u20138.","journal-title":"Int J Infect Dis"},{"key":"995_CR15","doi-asserted-by":"crossref","unstructured":"Helms J, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020.","DOI":"10.1056\/NEJMc2008597"},{"key":"995_CR16","doi-asserted-by":"crossref","unstructured":"Needham EJ, et al. Neurological implications of COVID-19 infections. Neurocrit Care. 2020.","DOI":"10.1007\/s12028-020-00978-4"},{"key":"995_CR17","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1373\/clinchem.2003.025437","volume":"12","author":"EC Hung","year":"2003","unstructured":"Hung EC, et al. Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome. Clin Chem. 2003;12:2108\u20139.","journal-title":"Clin Chem"},{"issue":"11","key":"995_CR18","first-page":"1128","volume":"23","author":"L He","year":"2003","unstructured":"He L, et al. Expression of the monoclonal antibody against nucleocapsid antigen of SARS-associated coronavirus in autopsy tissues from SARS patients. Di Yi Jun Yi Da Xue Xue Bao. 2003;23(11):1128\u201330.","journal-title":"Di Yi Jun Yi Da Xue Xue Bao"},{"issue":"1","key":"995_CR19","first-page":"26","volume":"15","author":"CS Hwang","year":"2006","unstructured":"Hwang CS. Olfactory neuropathy in severe acute respiratory syndrome: report of A case. Acta Neurol Taiwan. 2006;15(1):26\u20138.","journal-title":"Acta Neurol Taiwan"},{"issue":"2","key":"995_CR20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.micinf.2020.01.003","volume":"22","author":"F Yu","year":"2020","unstructured":"Yu F, et al. Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan. China. Microbes Infect. 2020;22(2):74\u20139.","journal-title":"China. Microbes Infect"},{"issue":"8","key":"995_CR21","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1086\/444461","volume":"41","author":"J Xu","year":"2005","unstructured":"Xu J, et al. Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis. Clin Infect Dis. 2005;41(8):1089\u201396.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"995_CR22","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/path.1560","volume":"203","author":"Y Ding","year":"2004","unstructured":"Ding Y, et al. Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol. 2004;203(2):622\u201330.","journal-title":"J Pathol"},{"issue":"15","key":"995_CR23","doi-asserted-by":"publisher","first-page":"7264","DOI":"10.1128\/JVI.00737-08","volume":"82","author":"J Netland","year":"2008","unstructured":"Netland J, et al. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol. 2008;82(15):7264\u201375.","journal-title":"J Virol"},{"issue":"2","key":"995_CR24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271\u2013280.e8.","journal-title":"Cell"},{"key":"995_CR25","doi-asserted-by":"crossref","unstructured":"Qi J, Zhou Y, Hua J, Zhang L, Bian J, Liu B, Zhao Z, Jin S. The scRNA-seq expression profiling of the receptor ACE2 and the cellular protease TMPRSS2 reveals human organs susceptible to COVID-19 infection. bioRxiv. 2020.","DOI":"10.1101\/2020.04.16.045690"},{"key":"995_CR26","doi-asserted-by":"crossref","unstructured":"Paniz-Mondolfi A, et al. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol. 2020.","DOI":"10.1002\/jmv.25915"},{"issue":"1","key":"995_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/v12010014","volume":"12","author":"M Desforges","year":"2019","unstructured":"Desforges M, et al. Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? Viruses. 2019;12(1):14.","journal-title":"Viruses"},{"key":"995_CR28","doi-asserted-by":"crossref","unstructured":"Machado C, Gutierrez J. Brainstem dysfunction in SARS-COV2 infection can be a potential cause of respiratory distress. 2020 (preprints).","DOI":"10.20944\/preprints202004.0330.v1"},{"issue":"3","key":"995_CR29","first-page":"e7352","volume":"12","author":"A Filatov","year":"2020","unstructured":"Filatov A, et al. Neurological complications of coronavirus disease (COVID-19): encephalopathy. Cureus. 2020;12(3):e7352.","journal-title":"Cureus"},{"issue":"10","key":"995_CR30","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1056\/NEJMoa1600651","volume":"374","author":"J Mlakar","year":"2016","unstructured":"Mlakar J, et al. Zika virus associated with microcephaly. N Engl J Med. 2016;374(10):951\u20138.","journal-title":"N Engl J Med"},{"issue":"2","key":"995_CR31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/PCC.0b013e3181cf4652","volume":"11","author":"SA Baltagi","year":"2010","unstructured":"Baltagi SA, et al. Neurological sequelae of 2009 influenza A (H1N1) in children: a case series observed during a pandemic. Pediatr Crit Care Med. 2010;11(2):179\u201384.","journal-title":"Pediatr Crit Care Med"},{"issue":"3","key":"995_CR32","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/ana.24730","volume":"80","author":"K Messacar","year":"2016","unstructured":"Messacar K, et al. Acute flaccid myelitis: a clinical review of US cases 2012\u20132015. Ann Neurol. 2016;80(3):326\u201338.","journal-title":"Ann Neurol"},{"key":"995_CR33","doi-asserted-by":"crossref","unstructured":"Dong Y., et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020.","DOI":"10.1542\/peds.2020-0702"},{"key":"995_CR34","doi-asserted-by":"crossref","unstructured":"Aggarwal G, Lippi G, Michael Henry B. Cerebrovascular disease is associated with an increased disease severity in patients with coronavirus disease 2019 (COVID-19): a pooled analysis of published literature. Int J Stroke. 2020. 1747493020921664.","DOI":"10.1177\/1747493020921664"},{"key":"995_CR35","doi-asserted-by":"crossref","unstructured":"Nathan N, Prevost B, Corvol H. Atypical presentation of COVID-19 in young infants. Lancet. 2020.","DOI":"10.1016\/S0140-6736(20)30980-6"},{"issue":"Suppl 1","key":"995_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12028-019-00751-2","volume":"30","author":"JI Suarez","year":"2019","unstructured":"Suarez JI, Macdonald RL. The end of the tower of babel in subarachnoid hemorrhage: common data elements at last. Neurocrit Care. 2019;30(Suppl 1):1\u20133.","journal-title":"Neurocrit Care"},{"issue":"Suppl 1","key":"995_CR37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s12028-019-00723-6","volume":"30","author":"JI Suarez","year":"2019","unstructured":"Suarez JI, et al. Common data elements for unruptured intracranial aneurysms and subarachnoid hemorrhage clinical research: a national institute for neurological disorders and stroke and national library of medicine project. Neurocrit Care. 2019;30(Suppl 1):4\u201319.","journal-title":"Neurocrit Care"},{"issue":"4","key":"995_CR38","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1161\/STROKEAHA.111.634352","volume":"43","author":"JL Saver","year":"2012","unstructured":"Saver JL, et al. Standardizing the structure of stroke clinical and epidemiologic research data: the National Institute of Neurological Disorders and Stroke (NINDS) Stroke Common Data Element (CDE) project. Stroke. 2012;43(4):967\u201373.","journal-title":"Stroke"},{"issue":"11","key":"995_CR39","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.apmr.2010.07.232","volume":"91","author":"AI Maas","year":"2010","unstructured":"Maas AI, et al. Common data elements for traumatic brain injury: recommendations from the interagency working group on demographics and clinical assessment. Arch Phys Med Rehabil. 2010;91(11):1641\u20139.","journal-title":"Arch Phys Med Rehabil"},{"issue":"Suppl 1","key":"995_CR40","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s12028-019-00725-4","volume":"30","author":"SH Chou","year":"2019","unstructured":"Chou SH, Macdonald RL, Keller E. Biospecimens and molecular and cellular biomarkers in aneurysmal subarachnoid hemorrhage studies: common data elements and standard reporting recommendations. Neurocrit Care. 2019;30(Suppl 1):46\u201359.","journal-title":"Neurocrit Care"},{"issue":"Suppl 1","key":"995_CR41","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s12028-019-00728-1","volume":"30","author":"KAM Hackenberg","year":"2019","unstructured":"Hackenberg KAM, et al. Common data elements for radiological imaging of patients with subarachnoid hemorrhage: proposal of a multidisciplinary research group. Neurocrit Care. 2019;30(Suppl 1):60\u201378.","journal-title":"Neurocrit Care"},{"issue":"Suppl 1","key":"995_CR42","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s12028-019-00726-3","volume":"30","author":"AL de Oliveira Manoel","year":"2019","unstructured":"de Oliveira Manoel AL, et al. Common data elements for unruptured intracranial aneurysms and aneurysmal subarachnoid hemorrhage: recommendations from the working group on hospital course and acute therapies-proposal of a multidisciplinary research group. Neurocrit Care. 2019;30(Suppl 1):36\u201345.","journal-title":"Neurocrit Care"},{"issue":"Suppl 1","key":"995_CR43","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12028-019-00736-1","volume":"30","author":"R Damani","year":"2019","unstructured":"Damani R, et al. Common data element for unruptured intracranial aneurysm and subarachnoid hemorrhage: recommendations from assessments and clinical examination workgroup\/subcommittee. Neurocrit Care. 2019;30(Suppl 1):28\u201335.","journal-title":"Neurocrit Care"},{"issue":"Suppl 1","key":"995_CR44","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s12028-019-00724-5","volume":"30","author":"P Bijlenga","year":"2019","unstructured":"Bijlenga P, et al. Common data elements for subarachnoid hemorrhage and unruptured intracranial aneurysms: recommendations from the working group on subject characteristics. Neurocrit Care. 2019;30(Suppl 1):20\u20137.","journal-title":"Neurocrit Care"},{"issue":"1","key":"995_CR45","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1177\/0141076814562718","volume":"108","author":"AB Hill","year":"2015","unstructured":"Hill AB. The environment and disease: association or causation? 1965. J R Soc Med. 2015;108(1):32\u20137.","journal-title":"J R Soc Med"},{"issue":"4","key":"995_CR46","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1017\/S0950268808001891","volume":"137","author":"PP Mortimer","year":"2009","unstructured":"Mortimer PP. Was encephalitis lethargica a post-influenzal or some other phenomenon? Time to re-examine the problem. Epidemiol Infect. 2009;137(4):449\u201355.","journal-title":"Epidemiol Infect"},{"key":"995_CR47","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1136\/jnnp.2006.106450","volume":"6","author":"J Vilensky","year":"2006","unstructured":"Vilensky J, Gilman S. Encephalitis lethargica: could this disease be recognised if the epidemic recurred? Pract Neurol. 2006;6:360\u20137.","journal-title":"Pract Neurol"},{"issue":"3","key":"995_CR48","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/13550280801995445","volume":"14","author":"S McCall","year":"2009","unstructured":"McCall S, Vilensky J, Gilman S, Taubenberger J. The relationship between encephalitis lethargica and influenza: a critical analysis. J Neurovirol. 2009;14(3):177\u201385.","journal-title":"J Neurovirol"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-020-00995-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-020-00995-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-020-00995-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T19:36:10Z","timestamp":1621625770000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-020-00995-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,22]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["995"],"URL":"https:\/\/doi.org\/10.1007\/s12028-020-00995-3","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,22]]},"assertion":[{"value":"22 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R21NS113037 (Chou), the University of Pittsburgh Dean\u2019s Faculty Advancement Award (Chou), Clinical and Translational Science Institute, University of Pittsburgh (Chou).  Dr. Chou reports grant funding from the National Institutes of Health. Dr. Ziai reports grant funding from the National Institutes of Health, and personal fees from CR Bard and Portola outside the submitted work. Dr. Fink reports grant funding from The National Institute of Health. Dr. Helbok reports personal fees from BARD Medical, Zoll Medical Corporation, and Integra Lifesciences outside the submitted work. The remaining authors have nothing to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study has been approved by The Institutional Review Board at The University of Pittsburgh, and by participating sites prior to data collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval\/informed consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}